Sale of 11,984 shares at $7.29 per share.
Reporting Person Anderman Todd · Officer Title Chief Legal Officer · Transaction Code S
Traded Oct 8, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001104659-26-115551 · filed 2026-10-13 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "OCULAR THERAPEUTIX, INC (OCUL)." Disclosed 2026-10-13. https://desqlong.com/cards/0001104659-26-115551-1 (retrieved 2026-10-14).